Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 5/20 | 0.42 |
| ▸ | GLP1R | P43220 | 8/20 | 0.40 |
| ▸ | SIRT1 | Q96EB6 | 2/20 | 0.38 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | KLK7 | P49862 | 1/20 | 0.37 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.37 |
| ▸ | TGM2 | P21980 | 2/20 | 0.36 |
| ▸ | TGM6 | O95932 | 1/20 | 0.36 |
| ▸ | F13A1 | P00488 | 1/20 | 0.36 |
| ▸ | TGM1 | P22735 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31624510 | 1.00 | SIRT2 (0.42) | SIRT2GLP1RSIRT1SIRT3BCHE | |
| SCHEMBL31624450 | 1.00 | SIRT2 (0.42) | SIRT2GLP1RSIRT1SIRT3BCHE | |
| SCHEMBL31624589 | 1.00 | SIRT2 (0.42) | SIRT2GLP1RSIRT1SIRT3BCHE | |
| SCHEMBL31631377 | 0.92 | SIRT2 (0.44) | SIRT2GLP1RSIRT1SIRT3BCHE | |
| SCHEMBL31624430 | 0.91 | SIRT2 (0.49) | SIRT2SIRT1SIRT3KLK7KLK5 | |
| SCHEMBL31624487 | 0.91 | SIRT2 (0.49) | SIRT2SIRT1SIRT3KLK7KLK5 | |
| SCHEMBL31624428 | 0.90 | GLP1R (0.49) | SIRT2GLP1RSIRT1SIRT3KLK7 | |
| SCHEMBL31624398 | 0.90 | GLP1R (0.49) | SIRT2GLP1RSIRT1SIRT3KLK7 | |
| SCHEMBL31624457 | 0.90 | GLP1R (0.49) | SIRT2GLP1RSIRT1SIRT3KLK7 | |
| SCHEMBL31624472 | 0.90 | GLP1R (0.49) | SIRT2GLP1RSIRT1SIRT3KLK7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025128626-A1 | HYBRID PEPTIDE COMPOUNDS HAVING A MODIFIED LYSINE RESIDUE | CARMOT THERAPEUTICS, INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025128624-A2 | HYBRID PEPTIDE COMPOUNDS HAVING A SUBSTITUTED TRYPTOPHAN RESIDUE OR A TERMINAL SUBSTITUENT | CARMOT THERAPEUTICS, INC. (US) | 2025-06-19 | — | — | WO | disclosed |